Skip to main content
Erschienen in: Der Pathologe 2/2012

01.03.2012 | Übersichten

Der hyalinisierende trabekuläre Tumor der Schilddrüse

Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor?

verfasst von: S. Ting, C. Puttinger, K.W. Schmid, PD. Dr. S.-Y. Sheu-Grabellus

Erschienen in: Die Pathologie | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der hyalinisierende trabekuläre Tumor der Schilddrüse ist ein seltener Tumor, der von den Follikelepithelzellen der Schilddrüse ausgeht und durch eine prominente intratrabekuläre Hyalinisierung gekennzeichnet ist. Aufgrund des Wachstumsmusters besteht eine Ähnlichkeit zum medullären Schilddrüsenkarzinom. Auffällige Kernatypien wie Kerninklusionen lassen an ein papilläres Schilddrüsenkarzinom denken. Deswegen ist die Dignitätsbeurteilung nach wie vor umstritten. Nachdem er aufgrund eindeutig fehlender Malignitätskriterien initial als Tumor mit benignem Verhalten eingestuft wurde, führten erste molekularpathologische Untersuchungen (Nachweis eines RET / PTC-Rearrangements) zu der Annahme, dass es sich um eine Variante des papillären Schilddrüsenkarzinoms handeln könnte. Neuere molekularpathologische Methoden wie die Bestimmung der microRNA, kurzer, nichtkodierender RNA, widerlegen jedoch diese Annahme. Der vorliegende Beitrag fasst die zur Diagnose wichtigen histomorphologischen Kriterien einschließlich neuer molekularpathologischer Erkenntnisse zusammen.
Literatur
1.
Zurück zum Zitat Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA (2006) Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal 3:17PubMedCrossRef Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA (2006) Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal 3:17PubMedCrossRef
2.
Zurück zum Zitat Carney JA, Hirokawa M, Lloyd RV et al (2008) Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 32:1877–1889PubMedCrossRef Carney JA, Hirokawa M, Lloyd RV et al (2008) Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 32:1877–1889PubMedCrossRef
3.
Zurück zum Zitat Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591PubMedCrossRef Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591PubMedCrossRef
4.
Zurück zum Zitat Casey MB, Sebo TJ, Carney JA (2004) Hyalinizing trabecular adenoma of the thyroid gland identification through MIB-1 staining of fine-needle aspiration biopsy smears. Am J Clin Pathol 122:506–510PubMedCrossRef Casey MB, Sebo TJ, Carney JA (2004) Hyalinizing trabecular adenoma of the thyroid gland identification through MIB-1 staining of fine-needle aspiration biopsy smears. Am J Clin Pathol 122:506–510PubMedCrossRef
5.
Zurück zum Zitat Casey MB, Sebo TJ, Carney JA (2004) Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol 28:859–867PubMedCrossRef Casey MB, Sebo TJ, Carney JA (2004) Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol 28:859–867PubMedCrossRef
6.
Zurück zum Zitat Chen YT, Kitabayashi N, Zhou XK et al (2008) MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139–1146PubMedCrossRef Chen YT, Kitabayashi N, Zhou XK et al (2008) MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139–1146PubMedCrossRef
7.
Zurück zum Zitat Cheung CC, Boerner SL, MacMillan CM et al (2000) Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24:1622–1626PubMedCrossRef Cheung CC, Boerner SL, MacMillan CM et al (2000) Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24:1622–1626PubMedCrossRef
8.
Zurück zum Zitat Del Sordo R, Sidoni A (2008) MIB-1 Cell membrane reactivity: a finding that should be interpreted carefully. Appl Immunohistochem Mol Morphol 16:568CrossRef Del Sordo R, Sidoni A (2008) MIB-1 Cell membrane reactivity: a finding that should be interpreted carefully. Appl Immunohistochem Mol Morphol 16:568CrossRef
9.
Zurück zum Zitat DeLellis RA, Williams ED (2004) Tumours of the thyroid and parathyroid. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Endocrine Organs. IARC Press, Lyon, pp 49–133 DeLellis RA, Williams ED (2004) Tumours of the thyroid and parathyroid. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Endocrine Organs. IARC Press, Lyon, pp 49–133
10.
Zurück zum Zitat Fonseca E, Nesland JM, Sobrinho-Simoes M (1997) Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31:330–335PubMedCrossRef Fonseca E, Nesland JM, Sobrinho-Simoes M (1997) Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31:330–335PubMedCrossRef
11.
Zurück zum Zitat Gaffney RL, Carney JA, Sebo TJ et al (2003) Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol 27:494–498PubMedCrossRef Gaffney RL, Carney JA, Sebo TJ et al (2003) Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol 27:494–498PubMedCrossRef
12.
Zurück zum Zitat Galgano MT, Mills SE, Stelow EB (2006) Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Am J Surg Pathol 30:1269–1273PubMedCrossRef Galgano MT, Mills SE, Stelow EB (2006) Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Am J Surg Pathol 30:1269–1273PubMedCrossRef
13.
Zurück zum Zitat Gowrishankar S, Pai SA, Carney JA (2008) Hyalinizing trabecular carcinoma of the thyroid gland. Histopathology 52:529–531PubMedCrossRef Gowrishankar S, Pai SA, Carney JA (2008) Hyalinizing trabecular carcinoma of the thyroid gland. Histopathology 52:529–531PubMedCrossRef
14.
Zurück zum Zitat He H, Jazdzewski K, Li W et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102:19075–19080PubMedCrossRef He H, Jazdzewski K, Li W et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102:19075–19080PubMedCrossRef
15.
Zurück zum Zitat Hirokawa M, Carney JA (2000) Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 24:575–578PubMedCrossRef Hirokawa M, Carney JA (2000) Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 24:575–578PubMedCrossRef
16.
Zurück zum Zitat Hirokawa M, Carney JA, Ohtsuki Y (2000) Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 24:877–881PubMedCrossRef Hirokawa M, Carney JA, Ohtsuki Y (2000) Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 24:877–881PubMedCrossRef
17.
Zurück zum Zitat Hirokawa M, Shimizu M, Manabe T et al (1995) Hyalinizing trabecular adenoma of the thyroid: its unusual cytoplasmic immunopositivity for MIB1. Pathol Int 45:399–401PubMedCrossRef Hirokawa M, Shimizu M, Manabe T et al (1995) Hyalinizing trabecular adenoma of the thyroid: its unusual cytoplasmic immunopositivity for MIB1. Pathol Int 45:399–401PubMedCrossRef
18.
Zurück zum Zitat Leonardo E, Volante M, Barbareschi M et al (2007) Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact? Appl Immunohistochem Mol Morphol 15:220–223PubMedCrossRef Leonardo E, Volante M, Barbareschi M et al (2007) Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact? Appl Immunohistochem Mol Morphol 15:220–223PubMedCrossRef
19.
Zurück zum Zitat McCluggage WG, Sloan JM (1996) Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 28:357–362PubMedCrossRef McCluggage WG, Sloan JM (1996) Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 28:357–362PubMedCrossRef
20.
Zurück zum Zitat Molberg K, Albores-Saavedra J (1994) Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 25:192–197PubMedCrossRef Molberg K, Albores-Saavedra J (1994) Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 25:192–197PubMedCrossRef
21.
Zurück zum Zitat Nikiforova MN, Nikiforov YE (2009) Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351–1361PubMedCrossRef Nikiforova MN, Nikiforov YE (2009) Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351–1361PubMedCrossRef
22.
Zurück zum Zitat Nikiforova MN, Tseng GC, Steward D et al (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600–1608PubMedCrossRef Nikiforova MN, Tseng GC, Steward D et al (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600–1608PubMedCrossRef
23.
Zurück zum Zitat Ohtsuki Y, Kimura M, Murao S et al (2009) Immunohistochemical and electron microscopy studies of a case of hyalinizing trabecular tumor of the thyroid gland, with special consideration of the hyalinizing mass associated with it. Med Mol Morphol 42:189–194PubMedCrossRef Ohtsuki Y, Kimura M, Murao S et al (2009) Immunohistochemical and electron microscopy studies of a case of hyalinizing trabecular tumor of the thyroid gland, with special consideration of the hyalinizing mass associated with it. Med Mol Morphol 42:189–194PubMedCrossRef
24.
Zurück zum Zitat Pallante P, Visone R, Ferracin M et al (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497–508PubMedCrossRef Pallante P, Visone R, Ferracin M et al (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497–508PubMedCrossRef
25.
Zurück zum Zitat Papotti M, Riella P, Montemurro F et al (1997) Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. Histopathology 31:525–533PubMedCrossRef Papotti M, Riella P, Montemurro F et al (1997) Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. Histopathology 31:525–533PubMedCrossRef
26.
Zurück zum Zitat Papotti M, Volante M, Giuliano A et al (2000) RET / PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24:1615–1621PubMedCrossRef Papotti M, Volante M, Giuliano A et al (2000) RET / PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24:1615–1621PubMedCrossRef
27.
Zurück zum Zitat Rhoden KJ, Unger K, Salvatore G et al (2006) RET / papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 91:2414–2423PubMedCrossRef Rhoden KJ, Unger K, Salvatore G et al (2006) RET / papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 91:2414–2423PubMedCrossRef
28.
Zurück zum Zitat Salvatore G, Chiappetta G, Nikiforov YE et al (2005) Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET / PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 41:816–821PubMedCrossRef Salvatore G, Chiappetta G, Nikiforov YE et al (2005) Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET / PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 41:816–821PubMedCrossRef
29.
Zurück zum Zitat Schmid KW, Mesewinkel F, Bocker W (1996) Hyalinizing trabecular adenoma of the thyroid – morphology and differential diagnosis. Acta Med Austriaca 23:65–68PubMed Schmid KW, Mesewinkel F, Bocker W (1996) Hyalinizing trabecular adenoma of the thyroid – morphology and differential diagnosis. Acta Med Austriaca 23:65–68PubMed
30.
Zurück zum Zitat Sheu SY, Grabellus F, Schwertheim S et al (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376–382PubMedCrossRef Sheu SY, Grabellus F, Schwertheim S et al (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376–382PubMedCrossRef
31.
Zurück zum Zitat Sheu SY, Vogel E, Worm K et al (2010) Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 56:632–640PubMedCrossRef Sheu SY, Vogel E, Worm K et al (2010) Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 56:632–640PubMedCrossRef
32.
Zurück zum Zitat Tetzlaff MT, Liu A, Xu X et al (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163–173PubMedCrossRef Tetzlaff MT, Liu A, Xu X et al (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163–173PubMedCrossRef
33.
Zurück zum Zitat Trovisco V, Vieira de Castro I, Soares P et al (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247–251PubMedCrossRef Trovisco V, Vieira de Castro I, Soares P et al (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247–251PubMedCrossRef
34.
Zurück zum Zitat Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264PubMedCrossRef Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264PubMedCrossRef
35.
Zurück zum Zitat Zhu Z, Ciampi R, Nikiforova MN et al (2006) Prevalence of RET / PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab 91:3603–3610PubMedCrossRef Zhu Z, Ciampi R, Nikiforova MN et al (2006) Prevalence of RET / PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab 91:3603–3610PubMedCrossRef
Metadaten
Titel
Der hyalinisierende trabekuläre Tumor der Schilddrüse
Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor?
verfasst von
S. Ting
C. Puttinger
K.W. Schmid
PD. Dr. S.-Y. Sheu-Grabellus
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Die Pathologie / Ausgabe 2/2012
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196
DOI
https://doi.org/10.1007/s00292-011-1498-z

Weitere Artikel der Ausgabe 2/2012

Der Pathologe 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.